S M Lenherr1,2, J Q Clemens1, B H Braffett3, R L Dunn1, P A Cleary3, C Kim4, W H Herman4, J M Hotaling2, A M Jacobson5, J S Brown6,7,8, H Wessells9, A V Sarma10. 1. Department of Urology, University of Michigan, Ann Arbor, MI, USA. 2. Department of Surgery, Division of Urology, University of Utah, Salt Lake City, UT, USA. 3. Biostatistics Center, George Washington University, Rockville, MD, USA. 4. Department of Medicine, University of Michigan, Ann Arbor, MI, USA. 5. Winthrop University Hospital, Research Institute, Mineola, NY, USA. 6. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA, USA. 7. Department of Urology, University of California, San Francisco, CA, USA. 8. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. 9. Department of Urology, University of Washington School of Medicine and Harborview Medical Center, Seattle, WA, USA. 10. Department of Urology, University of Michigan, Ann Arbor, MI, USA. asarma@umich.edu.
Abstract
AIMS: To study the impact of glycaemic control on urinary incontinence in women who participated in the Diabetes Control and Complications Trial (DCCT; 1983-1993) and its observational follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC; 1994-present). METHODS: Study participants were women who completed, at both years 10 (2003) and 17 (2010) of the EDIC follow-up, the urological assessment questionnaire (UroEDIC). Urinary incontinence was defined as self-reported involuntary leakage of urine that occurred at least weekly. Incident urinary incontinence was defined as weekly urinary incontinence present at EDIC year 17 but not at EDIC year 10. Multivariable regression models were used to examine the association of incident urinary incontinence with comorbid prevalent conditions and glycaemic control (mean HbA1c over the first 10 years of EDIC). RESULTS: A total of 64 (15.3%) women with Type 1 diabetes (mean age 43.6 ± 6.3 years at EDIC year 10) reported incident urinary incontinence at EDIC year 17. When adjusted for clinical covariates (including age, DCCT cohort assignment, DCCT treatment arm, BMI, insulin dosage, parity, hysterectomy, autonomic neuropathy and urinary tract infection in the last year), the mean EDIC HbA1c was associated with increased odds of incident urinary incontinence (odds ratio 1.03, 95% CI 1.01-1.06 per mmol/mol increase; odds ratio 1.41, 95% CI 1.07-1.89 per % HbA1c increase). CONCLUSIONS: Incident urinary incontinence was associated with higher HbA1c levels in women with Type 1 diabetes, independent of other recognized risk factors. These results suggest the potential for women to modify their risk of urinary incontinence with improved glycaemic control. (Clinical Trials Registry no: NCT00360815 and NCT00360893).
AIMS: To study the impact of glycaemic control on urinary incontinence in women who participated in the Diabetes Control and Complications Trial (DCCT; 1983-1993) and its observational follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC; 1994-present). METHODS: Study participants were women who completed, at both years 10 (2003) and 17 (2010) of the EDIC follow-up, the urological assessment questionnaire (UroEDIC). Urinary incontinence was defined as self-reported involuntary leakage of urine that occurred at least weekly. Incident urinary incontinence was defined as weekly urinary incontinence present at EDIC year 17 but not at EDIC year 10. Multivariable regression models were used to examine the association of incident urinary incontinence with comorbid prevalent conditions and glycaemic control (mean HbA1c over the first 10 years of EDIC). RESULTS: A total of 64 (15.3%) women with Type 1 diabetes (mean age 43.6 ± 6.3 years at EDIC year 10) reported incident urinary incontinence at EDIC year 17. When adjusted for clinical covariates (including age, DCCT cohort assignment, DCCT treatment arm, BMI, insulin dosage, parity, hysterectomy, autonomic neuropathy and urinary tract infection in the last year), the mean EDIC HbA1c was associated with increased odds of incident urinary incontinence (odds ratio 1.03, 95% CI 1.01-1.06 per mmol/mol increase; odds ratio 1.41, 95% CI 1.07-1.89 per % HbA1c increase). CONCLUSIONS: Incident urinary incontinence was associated with higher HbA1c levels in women with Type 1 diabetes, independent of other recognized risk factors. These results suggest the potential for women to modify their risk of urinary incontinence with improved glycaemic control. (Clinical Trials Registry no: NCT00360815 and NCT00360893).
Authors: Karen L Lifford; Gary C Curhan; Frank B Hu; Robert L Barbieri; Francine Grodstein Journal: J Am Geriatr Soc Date: 2005-11 Impact factor: 5.562
Authors: Mary K Townsend; Kim N Danforth; Bernard Rosner; Gary C Curhan; Neil M Resnick; Francine Grodstein Journal: Obstet Gynecol Date: 2007-08 Impact factor: 7.661
Authors: Sei J Lee; Andrew J Karter; Julie N Thai; Stephen K Van Den Eeden; Elbert S Huang Journal: J Womens Health (Larchmt) Date: 2013-09-13 Impact factor: 2.681
Authors: Shivani Bakre; Sarah K Holt; Mary Oerline; Barbara H Braffett; Rodica Pop-Busui; Hunter Wessells; Aruna V Sarma Journal: Neurourol Urodyn Date: 2021-10-21 Impact factor: 2.696